Merck nears $6 bln deal for Terns Pharma, FT reports
#Merck #Terns Pharma #acquisition #$6 billion #Financial Times #biotech #deal
📌 Key Takeaways
- Merck is close to acquiring Terns Pharma for approximately $6 billion.
- The potential deal was reported by the Financial Times.
- The acquisition would expand Merck's portfolio in the pharmaceutical sector.
- Terns Pharma is a biotechnology company focused on developing treatments.
🏷️ Themes
Mergers & Acquisitions, Pharmaceutical Industry
Entity Intersection Graph
No entity connections available yet for this article.